We are live on
!
Find out more
Tudor Investment Corp Portfolio holdings
AUM
$53.9B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
-1.47%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$19.5B
AUM Growth
+$3.8B
(+24%)
Cap. Flow
+$4.18B
Cap. Flow
% of AUM
21.4%
Top 10 Holdings %
Top 10 Hldgs %
34.26%
Holding
2,929
New
786
Increased
755
Reduced
667
Closed
671
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Allogene Therapeutics
ALLO
$683M
| $166K | ﹤0.01% |
71,340
-412
| -0.6% | -$1.22K |
|
|
FARO
2177
DELISTED
Faro Technologies
FARO
| $165K | ﹤0.01% |
10,284
-17,443
| -63% | -$323K |
|
2178
UNIFI
UFI
$120M
| $162K | ﹤0.01% |
27,511
-3,816
| -12% | -$22.7K |
|
2179
CALL
Nu Holdings
NU
$67.3B
| $157K | ﹤0.01% |
+12,200
| New | +$142K |
|
2180
Purple Innovation
PRPL
$28.7M
| $157K | ﹤0.01% |
6,026
-137
| -2% | -$4.82K |
|
|
HPP
2181
Hudson Pacific Properties
HPP
$787M
| $153K | ﹤0.01% |
4,538
-17,074
| -79% | -$644K |
|
2182
American Well
AMWL
$220M
| $152K | ﹤0.01% |
23,454
| – | – |
|
2183
Fate Therapeutics
FATE
$294M
| $149K | ﹤0.01% |
45,290
-2,792
| -6% | -$12.2K |
|
|
TBRG
2184
DELISTED
TruBridge
TBRG
| $148K | ﹤0.01% |
14,791
-35,845
| -71% | -$327K |
|
|
CLDT
2185
Chatham Lodging
CLDT
$601M
| $146K | ﹤0.01% |
17,104
-24,992
| -59% | -$225K |
|
2186
Akebia Therapeutics
AKBA
$241M
| $145K | ﹤0.01% |
142,274
| – | – |
|
2187
ProShares UltraPro Short QQQ
SQQQ
$1.67B
| $143K | ﹤0.01% |
+690
| New | +$176K |
|
|
WW
2188
DELISTED
WW International
WW
| $137K | ﹤0.01% |
117,100
-46,110
| -28% | -$76.7K |
|
2189
Real Brokerage
REAX
$523M
| $136K | ﹤0.01% |
+33,423
| New | +$140K |
|
2190
ADMA Biologics
ADMA
$2.11B
| $136K | ﹤0.01% |
+12,122
| New | +$102K |
|
2191
Amcor
AMCR
$21.4B
| $134K | ﹤0.01% |
2,747
-63,458
| -96% | -$3.08M |
|
|
SGMO
2192
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $130K | ﹤0.01% |
363,490
| – | – |
|
2193
ARKO Corp
ARKO
$505M
| $130K | ﹤0.01% |
20,661
+6,788
| +49% | +$36.5K |
|
2194
Alight
ALIT
$394M
| $128K | ﹤0.01% |
867
-2,456
| -74% | -$409K |
|
2195
Goodyear
GT
$1.78B
| $128K | ﹤0.01% |
+11,250
| New | +$138K |
|
2196
FIGS
FIGS
$2.47B
| $126K | ﹤0.01% |
+23,622
| New | +$121K |
|
2197
SGHC Ltd
SGHC
$6.65B
| $125K | ﹤0.01% |
38,751
| – | – |
|
2198
Precigen
PGEN
$2.32B
| $113K | ﹤0.01% |
71,464
| – | – |
|
|
RVNC
2199
DELISTED
Revance Therapeutics, Inc.
RVNC
| $111K | ﹤0.01% |
43,219
+10,878
| +34% | +$37.1K |
|
|
CMCT
2200
Creative Media & Community Trust
CMCT
$15M
| $110K | ﹤0.01% |
2
| – | – |
|
Similar funds
SCP
Tudor Investment Corp's Q2 2024 Portfolio in Review
As of Q2 2024, Tudor Investment Corp held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Tudor Investment Corp deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Tudor Investment Corp's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Tudor Investment Corp added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Tudor Investment Corp's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Tudor Investment Corp fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Tudor Investment Corp's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Tudor Investment Corp opened 786 new positions and closed 671 in Q2 2024.
- Tudor Investment Corp's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.